1/22/2013

Enrollment has been wrapped up for a midstage study evaluating the safety, efficacy and pharmacokinetics of GlycoMimetics' experimental drug GMI-1070 among sickle cell disease patients in vaso-occlusive crisis. Preliminary findings from the 76-patient trial could be released next quarter.

Related Summaries